Search results for: Healthcare Systems
Filter search results
Primary Care and the NHS Reforms: A Manager’s View
1 March 2000
…heart of the reforms. This tends to be an overarching concern that all governments have with their health care systems. Thus, Labour’s reforms can be seen as part of an…
Reducing Harm to Patients in the National Health Service. Will the Government’s Compensation Proposals Help?
1 December 2003
…for negligence, discusses the issues the government’s proposals raise, and sets out how these proposals can be made more effective by ensuring a link between safety systems and compensation mechanisms….
OHE Lunchtime Seminar: Health Technology Assessment Scientific and Outcomes Advice on Medicinal Drug Development
4 October 2016, 11:00pm
…(Medicines and Healthcare products Regulatory Agency, MHRA, and European Medicines Agency, EMA). Despite these efforts HTA SA is not routinely integrated into the clinical development of new medicines and it…
OHE’s 2016 Annual Lecture with Dame Sally Davies: 10 Years of NIHR: Achievements and Challenges for the Next Decade
7 November 2016, 12:00am
…the IOM termed The Learning Healthcare System with the use of Big Data and an emphasis on gathering «real world evidence» by tracking NHS patients through observational studies and more…
International Drug Pricing Transparency
20 July 2020, 11:00pm
…essential for differential pricing, which in turn is viewed as necessary to balance patient access with continual innovation in drug development. Rising healthcare costs, fuelled by a changing political perspective…
The Value of a QALY Towards the End of Life and its Determinants: Experimental Evidence
20 June 2022, 11:00pm
…economics. The Value of a QALY towards the End of Life and its Determinants: Experimental Evidence OBJECTIVE End-of-life healthcare expenditure (HCE) is a substantial contributor to overall HCE. A widely…
Reminder: 2010 Lecture on US Health Reform
14 June 2010
…School of Medicine. Entitled ‘US Healthcare Reform: Monumental Health System Transformation or Fatally Flawed Compromise?’, his remarks will focus on the national health care legislation recently enacted in the US. Join us in…
EU Approval of Biosimilars
8 July 2010
…and summarises the remarks of Dr. Gopalan Narayanan of the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA). Biosimilar products in the European Union (EU) must go through a centralised procedure that licenses…
Part 1: 2010 Lecture on US Health Reform
20 July 2010
…Care and Outcomes Research at the School of Medicine. His presentation, ‘US Healthcare Reform: Monumental Health System Transformation or Fatally Flawed Compromise?’, is summarised in two blog posts. The first of…